Use of respiratory medication in five Latin American cities: The PLATINO study

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 5, 2008, Pages 788-793

  Montes de Oca, Maria ^a   Tálamo, Carlos ^a   Perez Padilla, Rogelio ^b   Lopez, Maria Victorina ^c   Muiño, Adriana ^c   Jardim, José Roberto B ^d   Valdivia, Gonzalo ^e   Pertuzé, Julio ^e   Moreno, Dolores ^a   Halbert, Ronald J ^f   Menezes, Ana Maria B ^g  

^a HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^b Institute of Respiratory Diseases   (Mexico)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Bronchodilators; Chronic obstructive pulmonary disease; Epidemiology; Prevalence; Steroids

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRAZIL; CHILE; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEXICO; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; SOUTH AND CENTRAL AMERICA; TUBERCULOSIS; URUGUAY; VENEZUELA; WHEEZING;

ADRENAL CORTEX HORMONES; AGE FACTORS; AGED; ASTHMA; BODY MASS INDEX; BRONCHODILATOR AGENTS; CITIES; COUGH; DRUG UTILIZATION REVIEW; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; INTERVIEWS AS TOPIC; LATIN AMERICA; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEX FACTORS; SPIROMETRY; TUBERCULOSIS; URBAN HEALTH; URBAN POPULATION;

EID: 51049083805     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.06.003     Document Type: Article

References (30)

1. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
2. Menezes A.M., Perez-Padilla R., Jardim J.R., Muiño A., Lopez M.V., Valdivia G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 366 (2005) 1875-1881
3. Mannino D.M., Gagnon R.C., Petty T.L., and Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 160 (2000) 1683-1689
4. Halbert R.J., Natoli J.L., Gano A., Badamgarav E., Buist A.S., and Mannino D.M. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28 (2006) 523-532
5. Buist A.S., McBurnie M.A., Vollmer W.M., Gillespie S., Burney P., Mannino D.M., et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370 (2007) 741-750
6. Mannino D.M., and Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4 (2007) 502-506
7. Moorman J.E., Rudd R.A., Johnson C.A., King M., Minor P., Bailey C., et al. National surveillance for asthma-United States, 1980-2004. MMWR Surveill Summ 56 (2007) 1-54
8. Celli B.R., and MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
9. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S., and GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) work-shop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
10. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA), 2006. Available from: 〈www.ginasthma.org〉. Date last updated, 2006.
11. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31 (2008) 143-178
12. Tálamo C., de Oca M.M., Halbert R., Perez-Padilla R., Jardim J.R., Muiño A., et al. Diagnostic labeling of COPD in five Latin American cities. Chest 131 (2007) 60-67
13. Otoom S.A., and Sequeira R.P. Health care providers' perceptions of the problems and causes of irrational use of drugs in two Middle East countries. Int J Clin Pract 60 (2006) 565-570
14. Montanaro N., Magrini N., Vaccheri A., and Battilana M. Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989. Eur J Clin Pharmacol 42 (1992) 401-408
15. Bregnhøj L., Thirstrup S., Kristensen M.B., Bjerrum L., and Sonne J. Prevalence of inappropriate prescribing in primary care. Pharm World Sci 29 (2007) 109-115
16. Steinman M.A., Landefeld C.S., Rosenthal G.E., Berthenthal D., Sen S., and Kaboli P.J. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 54 (2006) 1516-1523
17. Curtis L.H., Ostbye T., Sendersky V., Hutchison S., Dans P.E., Wright A., et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med 164 (2004) 1621-1625
18. Simoni M., Carrozzi L., Baldacci S., Borbotti M., Pistelli F., Di Pede F., et al. Respiratory symptoms/diseases, impaired lung function, and drug use in two Italian general population samples. Respir Med 102 (2008) 82-91
19. Lucas A., Smeenk F., Smeele I., and van Schayck C. Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract 25 (2008) 86-91
20. Menezes A.M., Victora C.G., Perez-Padilla R., and The PLATINO Team. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. BMC Med Res Methodol 4 (2004) 15
21. Pérez-Padilla R., Valdivia G., Muiño A., López M.V., Márquez M.N., Montes de Oca M., et al. Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over. Arch Bronconeumol 42 (2006) 317-325
22. López M.V., Muiño A., Pérez-Padilla R., Jardim J.R., Tálamo C., Montes de Oca M., et al. Tratamiento de la enfermedad pulmonar obstructiva crónica en cinco ciudades de América Latina: estudio PLATINO. Arch Bronconeumol 44 (2008) 58-64
23. Montes de Oca M., Tálamo C., Perez-Padilla R., Jardim J.R., Muiño A., Lopez M.V., et al. Chronic obstructive pulmonary disease and body mass index in five Latin America cities: The PLATINO study. Respir Med 102 (2008) 642-650
24. Renwick D.S., and Connolly M.J. Prevalence and treatment of chronic airways obstruction in adults over the age of 45. Thorax 51 (1996) 164-168
25. de Miguel Díez J., Izquierdo Alonso J.L., Molina París J., Bellón Cano J.M., Rodríguez González-Moro J.M., and de Lucas Ramos P. Factors affecting drug prescription in patients with stable COPD: results from a multicenter Spanish study (IDENTEPOC). Arch Bronconeumol 39 (2003) 195-202
26. Roche N., Lepage T., Bourcereau J., and Terrioux P. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J 18 (2001) 903-908
27. Halbert R.J., Natoli J.L., Gano A., Badamgarav E., Buist A.S., and Mannino D.M. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28 (2006) 523-532
28. Braman S.S. The global burden of asthma. Chest 130 (2006) 4S-12S
29. Joyce D.P., Chapman K.R., and Kesten S. Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms. Chest 109 (1996) 697-701
30. LindenSmith J., Morrison D., Deveau C., and Hernandez P. Overdiagnosis of asthma in the community. Can Respir J 11 (2004) 111-116